Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 2 July 2009, Vol. 114, No. 1, pp. 219-222.
Prepublished online as a Blood First Edition Paper on May 1, 2009; DOI 10.1182/blood-2009-03-209833.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2009-03-209833v1
114/1/219    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baerlocher, G. M.
Right arrow Articles by Tichelli, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baerlocher, G. M.
Right arrow Articles by Tichelli, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted March 10, 2009
Accepted April 22, 2009

Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic GVHD and a female donor gender

Gabriela M. Baerlocher*, Alicia Rovo, Astrid Muller, Sybille Matthey, Martin Stern, Jorg Halter, Dominik Heim, Johannes Rischewski, Alois Gratwohl, and Andre Tichelli

Department of Hematology, University Hospital, Bern, Switzerland
Department of Hematology, University Hospital, Basel, Switzerland
Department of Clinical Research, University Bern, Bern, Switzerland
Department of Oncology, Children's University Hospital Basel, Basel, Switzerland

* Corresponding author; email: gabriela.baerlocher{at}insel.ch.

In this single center, cross-sectional study, we evaluated 44 very long-term survivors with a median follow-up of 17.5 (range 11-26) years after HSCT. We assessed in HLA-identical donor and recipient sibling pairs the telomere length difference and searched for its relationship with clinical factors. The telomere length (kb mean±1std) was significantly shorter in all recipient blood cells compared to their donors (p<0.01); granulocytes (6.5±0.9 versus 7.1±0.9), naive/memory T-cells (5.7±1.2 versus 6.6±1.2; 5.2±1.0 versus 5.7±0.9), B-cells (7.1±1.1 versus 7.8±1.1), NK/NKT-cells (4.8±1.0 versus 5.6±1.3). Chronic GVHD (p< 0.04) and a female donor (p< 0.04) were associated with a higher telomere length difference between donor and recipient. Critically short telomeres have been described in degenerative diseases and secondary malignancies. If this hypothesis can be confirmed, identification of recipients at risk for cellular senescence could become part of monitoring long-term survivors after HSCT.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020